Preclinical
Dragonfly Therapeutics struck a licensing agreement worth up to $695 million with Merck. Merck will license exclusive rights to Dragonfly’s TriNKET technology platform for a number of solid-tumor programs, the company announced today.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Some cancer cells have a remarkable and frightening sense of self-preservation to avoid immunotherapy treatments. That is the finding from a new study conducted by researchers at the Fred Hutchinson Cancer Research Center in Seattle.
Incidence of Alzheimer’s disease is projected to double in the next 40 years unless a cure or preventive measures are found. The U.S. Centers for Disease Control and Prevention published a new report in the journal Alzheimer’s & Dementia projecting the disease’s likely expansion, and for the first time, forecasted the disease by race and ethnicity.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Cynata Therapeutics Limited is pleased to announce data from a preclinical model demonstrating that its proprietary Cymerus™ mesenchymal stem cells (MSCs) significantly ameliorate the effects of cytokine release syndrome (CRS), a potentially severe and life-threatening adverse reaction to cancer immunotherapy.
A recent survey by the Pew Research Center found that 57 percent of Americans surveyed thought it was appropriate to use genetically engineered animals to grow organs for human transplants.
Akari Therapeutics Announces New Preclinical Rheumatoid Arthritis Data and New Clinical Data in Patients with Bullous Pemphigoid, Highlighting Potential Advantages of Coversin’s Bifunctional Activity Inhibiting Both the Complement and Leukotriene Inflammatory Pathways
Amicus Therapeutics, headquartered in Cranbury, New Jersey, held a Type C meeting with the U.S. Food and Drug Administration (FDA) regarding its regulatory path for AT-GAA for Pompe Disease. The company released its plans for the drug.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
PRESS RELEASES